Creative Planning
HAE icon

Creative Planning’s Haemonetics HAE Stock Holding History

Creative Planning’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1M Sell
17,831
-9,047
-34% -$589K ﹤0.01% 2448
2025
Q4 		$2.15M Buy
26,878
+20,763
+340% +$1.4M ﹤0.01% 1674
2025
Q3 		$298K Sell
6,115
-4,419
-42% -$274K ﹤0.01% 3148
2025
Q2 		$786K Buy
10,534
+335
+3% +$22.2K ﹤0.01% 2064
2025
Q1 		$648K Buy
10,199
+1,867
+22% +$127K ﹤0.01% 2068
2024
Q4 		$651K Buy
8,332
+4,134
+98% +$332K ﹤0.01% 1983
2024
Q3 		$337K Sell
4,198
-247
-6% -$20K ﹤0.01% 2429
2024
Q2 		$368K Buy
+4,445
New +$391K ﹤0.01% 2194
2017
Q3 		– Sell
-203
Closed -$8K – 2662
2017
Q2 		$8K Buy
+203
New +$8.34K ﹤0.01% 3747
2015
Q4 		– Sell
-52
Closed -$2K – 4475
2015
Q3 		$2K Buy
+52
New +$1.96K ﹤0.01% 3939
2014
Q4 		– Sell
-45
Closed -$2K – 4229
2014
Q3 		$2K Buy
+45
New +$1.61K ﹤0.01% 3656
2014
Q2 		– Sell
-200
Closed -$7K – 3852
2014
Q1 		$7K Hold
200
– – ﹤0.01% 2922
2013
Q4 		$8K Hold
200
– – ﹤0.01% 2659
2013
Q3 		$8K Buy
200
+182
+1,011% +$7.64K ﹤0.01% 2549
2013
Q2 		$1K Buy
+18
New +$729 ﹤0.01% 2940

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Creative Planning's HAE Position: Q1 2026 in Review

Creative Planning reduced its Haemonetics (HAE) stake by 34% in Q1 2026, selling an estimated $589K and leaving 17,831 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #2448.

Creative Planning first reported a position in HAE in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.15M in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Creative Planning held 17,831 shares of Haemonetics worth $1M as of Q1 2026.
  • Creative Planning sold 9,047 Haemonetics shares in Q1 2026, an estimated $589K.
  • Haemonetics made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2448 holding.
  • Creative Planning first reported a position in Haemonetics in Q2 2013 and has held it in 15 quarters since.
  • Creative Planning's Haemonetics position peaked at $2.15M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.